Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dermira, Inc. (DERM) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dermira, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1557883.
Total stock buying since 2014: $784,786,125.
Total stock sales since 2014: $13,138,244.
Total stock option exercises since 2014: $678,365.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 40,926,025 | $767,362,968 | 0 | $0 | 0 | $0 |
| 2019 | 23,419 | $199,998 | 70,419 | $858,636 | 250,920 | $46,155 |
| 2018 | 49,805 | $479,489 | 33,258 | $855,181 | 97,991 | $40,324 |
| 2017 | 30,000 | $690,940 | 119,024 | $3,665,607 | 118,416 | $133,631 |
| 2016 | 0 | $0 | 223,318 | $6,920,583 | 96,741 | $408,384 |
| 2015 | 0 | $0 | 30,000 | $838,237 | 9,051 | $49,871 |
| 2014 | 1,003,008 | $16,052,730 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-02 | 40,926,025 | $767,362,968 | 0 | $0 | 0 | $0 |
| 2019-12 | 0 | $0 | 6,000 | $81,000 | 0 | $0 |
| 2019-09 | 0 | $0 | 6,000 | $52,638 | 0 | $0 |
| 2019-08 | 23,419 | $199,998 | 23,419 | $199,998 | 63,253 | $3,525 |
| 2019-06 | 0 | $0 | 0 | $0 | 21,000 | $0 |
| 2019-05 | 0 | $0 | 0 | $0 | 131,667 | $0 |
| 2019-04 | 0 | $0 | 35,000 | $525,000 | 35,000 | $42,630 |
| 2018-10 | 0 | $0 | 4,000 | $55,000 | 0 | $0 |
| 2018-08 | 0 | $0 | 0 | $0 | 44,985 | $0 |
| 2018-07 | 25,780 | $239,948 | 0 | $0 | 0 | $0 |
| 2018-06 | 24,025 | $239,541 | 0 | $0 | 21,000 | $0 |
| 2018-05 | 0 | $0 | 0 | $0 | 10,000 | $9,860 |
| 2018-03 | 0 | $0 | 3,600 | $90,668 | 3,000 | $3,654 |
| 2018-02 | 0 | $0 | 3,600 | $102,963 | 3,000 | $3,654 |
| 2018-01 | 0 | $0 | 22,058 | $606,550 | 16,006 | $23,156 |
| 2017-12 | 0 | $0 | 8,600 | $234,869 | 10,000 | $11,020 |
| 2017-11 | 0 | $0 | 5,600 | $153,702 | 5,000 | $4,930 |
| 2017-10 | 0 | $0 | 13,100 | $379,098 | 5,000 | $4,930 |
| 2017-09 | 0 | $0 | 10,100 | $275,471 | 9,500 | $9,367 |
| 2017-08 | 30,000 | $690,940 | 1,100 | $28,076 | 25,892 | $493 |
| 2017-07 | 0 | $0 | 7,500 | $220,307 | 5,000 | $4,930 |
| 2017-06 | 0 | $0 | 7,500 | $212,654 | 5,000 | $4,929 |
| 2017-05 | 0 | $0 | 12,312 | $408,820 | 9,812 | $17,828 |
| 2017-04 | 0 | $0 | 12,303 | $415,205 | 9,803 | $17,815 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-20 | Eli Lilly & Co (10% Owner) | Buy | 40,926,025 | 18.75 | 767,362,968 |
| 2019-12-24 | Fust Matthew K | Sale | 3,000 | 15.00 | 45,000 |
| 2019-12-12 | Fust Matthew K | Sale | 3,000 | 12.00 | 36,000 |
| 2019-09-12 | Fust Matthew K | Sale | 6,000 | 8.77 | 52,638 |
| 2019-08-19 | Pena Luis C. (Chief Development Officer) | Sale | 23,419 | 8.54 | 199,998 |
| 2019-08-19 | Pena Luis C. (Chief Development Officer) | Option Ex | 3,576 | .99 | 3,525 |
| 2019-08-19 | Wiggans Thomas G (CEO & Chairman of the Board) | Buy | 23,419 | 8.54 | 199,998 |
| 2019-08-15 | Lyons-williams Lori (Chief Commercial Officer) | Option Ex | 3,189 | .00 | 0 |
| 2019-08-15 | Pena Luis C. (Chief Development Officer) | Option Ex | 8,627 | .00 | 0 |
| 2019-08-15 | Griffith Christopher M. (Chief Business & Strategy Officer) | Option Ex | 4,473 | .00 | 0 |
| 2019-08-15 | Guggenhime Andrew (CFO) | Option Ex | 9,975 | .00 | 0 |
| 2019-08-15 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 7,913 | .00 | 0 |
| 2019-08-15 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 25,500 | .00 | 0 |
| 2019-06-12 | Sebelius Kathleen | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Nunn Jason Raleigh | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Fust Matthew K | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Cohen David E | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Mcdade Mark | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Ringo William R | Option Ex | 3,000 | .00 | 0 |
| 2019-06-12 | Craves Fred B | Option Ex | 3,000 | .00 | 0 |
| 2019-05-17 | Horan Christopher (Chief Technical Ops Officer) | Option Ex | 26,667 | .00 | 0 |
| 2019-05-17 | Lyons-williams Lori (Chief Commercial Officer) | Option Ex | 30,000 | .00 | 0 |
| 2019-05-17 | Pena Luis C. (Chief Development Officer) | Option Ex | 25,000 | .00 | 0 |
| 2019-05-17 | Griffith Christopher M. (Chief Business & Strategy Officer) | Option Ex | 25,000 | .00 | 0 |
| 2019-05-17 | Guggenhime Andrew (CFO) | Option Ex | 25,000 | .00 | 0 |
| 2019-04-08 | Bauer Eugene A (Chief Medical Officer) | Sale | 35,000 | 15.00 | 525,000 |
| 2019-04-08 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 35,000 | 1.22 | 42,630 |
| 2018-10-19 | Fust Matthew K | Sale | 4,000 | 13.75 | 55,000 |
| 2018-08-15 | Lyons-williams Lori (Chief Commercial Officer) | Option Ex | 1,063 | .00 | 0 |
| 2018-08-15 | Pena Luis C. (Chief Development Officer) | Option Ex | 6,500 | .00 | 0 |
| 2018-08-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 2,835 | .00 | 0 |
| 2018-08-15 | Guggenhime Andrew (COO and CFO) | Option Ex | 8,075 | .00 | 0 |
| 2018-08-15 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 6,012 | .00 | 0 |
| 2018-08-15 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 20,500 | .00 | 0 |
| 2018-07-09 | Wiggans Thomas G (CEO & Chairman of the Board) | Buy | 12,000 | 10.00 | 119,952 |
| 2018-07-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Buy | 13,780 | 8.71 | 119,996 |
| 2018-06-25 | Wiggans Thomas G (CEO & Chairman of the Board) | Buy | 12,150 | 9.84 | 119,592 |
| 2018-06-18 | Wiggans Thomas G (CEO & Chairman of the Board) | Buy | 11,875 | 10.10 | 119,949 |
| 2018-06-13 | Sebelius Kathleen | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Nunn Jason Raleigh (Director) | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Fust Matthew K | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Cohen David E | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Mcdade Mark | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Ringo William R | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | Craves Fred B | Option Ex | 3,000 | .00 | 0 |
| 2018-05-15 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 10,000 | .99 | 9,860 |
| 2018-03-02 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 25.00 | 62,500 |
| 2018-03-02 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 2,500 | 1.22 | 3,045 |
| 2018-03-01 | Cohen David E | Sale | 600 | 25.85 | 15,510 |
| 2018-03-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 500 | 25.32 | 12,658 |
| 2018-03-01 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 500 | 1.22 | 609 |
| 2018-02-01 | Cohen David E | Sale | 600 | 28.87 | 17,322 |
| 2018-02-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 3,000 | 28.55 | 85,641 |
| 2018-02-01 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 3,000 | 1.22 | 3,654 |
| 2018-01-02 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Sale | 18,458 | 27.48 | 507,133 |
| 2018-01-02 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 14,030 | 1.48 | 20,750 |
| 2018-01-02 | Cohen David E | Sale | 600 | 28.03 | 16,818 |
| 2018-01-02 | Bauer Eugene A (Chief Medical Officer) | Sale | 3,000 | 27.53 | 82,599 |
| 2018-01-02 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 1,976 | 1.22 | 2,406 |
| 2017-12-21 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | 1.22 | 6,090 |
| 2017-12-18 | Bauer Eugene A (Chief Medical Officer) | Sale | 3,000 | 27.34 | 82,011 |
| 2017-12-13 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 27.51 | 137,565 |
| 2017-12-13 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2017-12-01 | Cohen David E | Sale | 600 | 25.49 | 15,293 |
| 2017-11-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 27.52 | 137,610 |
| 2017-11-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2017-11-01 | Cohen David E | Sale | 600 | 26.82 | 16,092 |
| 2017-10-11 | Bauer Eugene A (Chief Medical Officer) | Sale | 7,500 | 30.04 | 225,300 |
| 2017-10-10 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 27.52 | 137,605 |
| 2017-10-10 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2017-10-02 | Cohen David E | Sale | 600 | 26.99 | 16,193 |
| 2017-09-18 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 9,500 | 27.51 | 261,335 |
| 2017-09-18 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 9,500 | .99 | 9,367 |
| 2017-09-01 | Cohen David E | Sale | 600 | 23.56 | 14,136 |
| 2017-08-28 | Cohen David E | Sale | 600 | 23.81 | 14,286 |
| 2017-08-15 | Pena Luis C. (Chief Development Officer) | Option Ex | 3,813 | .00 | 0 |
| 2017-08-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 1,391 | .00 | 0 |
| 2017-08-15 | Guggenhime Andrew (COO and CFO) | Option Ex | 4,750 | .00 | 0 |
| 2017-08-15 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 3,438 | .00 | 0 |
| 2017-08-15 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 12,000 | .00 | 0 |
| 2017-08-14 | Craves Fred B | Buy | 10,000 | 23.95 | 239,460 |
| 2017-08-10 | Craves Fred B | Buy | 20,000 | 22.57 | 451,480 |
| 2017-08-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 500 | 27.58 | 13,790 |
| 2017-08-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 500 | .99 | 493 |
| 2017-07-05 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 30.00 | 75,007 |
| 2017-07-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 29.06 | 145,300 |
| 2017-07-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2017-06-20 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 30.01 | 75,032 |
| 2017-06-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 1,121 | 27.61 | 30,950 |
| 2017-06-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 1,121 | .99 | 1,105 |
| 2017-06-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 3,879 | 27.50 | 106,672 |
| 2017-06-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 3,879 | .99 | 3,824 |
| 2017-05-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Sale | 1,312 | 27.07 | 35,515 |
| 2017-05-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 1,312 | 1.48 | 1,940 |
| 2017-05-01 | Ringo William R | Sale | 500 | 34.06 | 17,030 |
| 2017-05-01 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2017-05-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 33.65 | 84,115 |
| 2017-05-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 8,000 | 34.02 | 272,160 |
| 2017-05-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 8,000 | .99 | 7,888 |
| 2017-04-17 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Sale | 1,303 | 33.97 | 44,266 |
| 2017-04-17 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2017-04-03 | Ringo William R | Sale | 500 | 34.03 | 17,015 |
| 2017-04-03 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2017-04-03 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 33.72 | 84,292 |
| 2017-04-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 8,000 | 33.70 | 269,632 |
| 2017-04-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 8,000 | .99 | 7,888 |
| 2017-03-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Sale | 1,303 | 36.05 | 46,978 |
| 2017-03-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2017-03-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 4,000 | 37.60 | 150,416 |
| 2017-03-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 4,000 | .99 | 3,944 |
| 2017-03-01 | Ringo William R | Sale | 500 | 35.09 | 17,547 |
| 2017-03-01 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2017-03-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 34.20 | 85,490 |
| 2017-03-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 34.48 | 379,225 |
| 2017-03-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 11,000 | .99 | 10,846 |
| 2017-02-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Sale | 1,303 | 30.95 | 40,330 |
| 2017-02-15 | Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2017-02-15 | Ringo William R | Sale | 500 | 32.00 | 16,000 |
| 2017-02-15 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2017-02-14 | Bauer Eugene A (Chief Medical Officer) | Sale | 1,505 | 30.00 | 45,153 |
| 2017-02-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 995 | 30.00 | 29,851 |
| 2017-02-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 29.66 | 148,290 |
| 2017-02-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2017-01-17 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 29.51 | 38,451 |
| 2017-01-17 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2017-01-04 | Ringo William R | Sale | 500 | 32.00 | 16,000 |
| 2017-01-04 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2017-01-04 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 3,000 | 32.51 | 97,542 |
| 2017-01-04 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 3,000 | .99 | 2,958 |
| 2017-01-03 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 30.07 | 75,172 |
| 2017-01-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 5,000 | 30.19 | 150,960 |
| 2017-01-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 5,000 | .99 | 4,930 |
| 2016-12-16 | Ringo William R | Sale | 125 | 32.00 | 4,000 |
| 2016-12-16 | Ringo William R | Option Ex | 125 | 16.00 | 2,000 |
| 2016-12-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 30.70 | 40,004 |
| 2016-12-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2016-12-14 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 30.85 | 77,130 |
| 2016-12-01 | Ringo William R | Sale | 375 | 32.00 | 12,000 |
| 2016-12-01 | Ringo William R | Option Ex | 375 | 16.00 | 6,000 |
| 2016-12-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 31.04 | 341,385 |
| 2016-11-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 34.20 | 44,569 |
| 2016-11-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2016-11-09 | Ringo William R | Sale | 500 | 32.30 | 16,149 |
| 2016-11-09 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2016-11-09 | Guggenhime Andrew (COO and CFO) | Sale | 4,100 | 35.02 | 143,582 |
| 2016-11-09 | Guggenhime Andrew (COO and CFO) | Option Ex | 4,100 | 5.51 | 22,591 |
| 2016-11-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 31.19 | 343,090 |
| 2016-10-17 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 32.33 | 42,125 |
| 2016-10-17 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2016-10-11 | Guggenhime Andrew (COO and CFO) | Sale | 10,900 | 34.66 | 377,848 |
| 2016-10-11 | Guggenhime Andrew (COO and CFO) | Option Ex | 10,900 | 5.51 | 60,059 |
| 2016-10-03 | Ringo William R | Sale | 500 | 34.25 | 17,125 |
| 2016-10-03 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2016-10-03 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 34.70 | 381,700 |
| 2016-09-19 | Guggenhime Andrew (COO and CFO) | Sale | 15,000 | 35.01 | 525,150 |
| 2016-09-19 | Guggenhime Andrew (COO and CFO) | Option Ex | 15,000 | 5.51 | 82,650 |
| 2016-09-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 32.77 | 42,698 |
| 2016-09-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2016-09-12 | Guggenhime Andrew (COO and CFO) | Sale | 10,000 | 32.53 | 325,300 |
| 2016-09-12 | Guggenhime Andrew (COO and CFO) | Option Ex | 10,000 | 5.51 | 55,100 |
| 2016-09-01 | Ringo William R | Sale | 500 | 32.00 | 16,000 |
| 2016-09-01 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2016-09-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 31.30 | 344,355 |
| 2016-08-15 | Pena Luis C. (Chief Development Officer) | Option Ex | 1,000 | .00 | 0 |
| 2016-08-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 31.75 | 41,370 |
| 2016-08-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,663 | .99 | 1,639 |
| 2016-08-15 | Guggenhime Andrew (COO and CFO) | Option Ex | 1,188 | .00 | 0 |
| 2016-08-15 | Bauer Eugene A (Chief Medical Officer) | Option Ex | 875 | .00 | 0 |
| 2016-08-15 | Wiggans Thomas G (CEO & Chairman of the Board) | Option Ex | 3,000 | .00 | 0 |
| 2016-08-11 | Guggenhime Andrew (COO and CFO) | Sale | 10,000 | 31.02 | 310,170 |
| 2016-08-11 | Guggenhime Andrew (COO and CFO) | Option Ex | 10,000 | 5.51 | 55,100 |
| 2016-08-01 | Ringo William R | Sale | 500 | 33.65 | 16,825 |
| 2016-08-01 | Ringo William R | Option Ex | 500 | 16.00 | 8,000 |
| 2016-08-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 33.18 | 82,950 |
| 2016-08-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 32.91 | 362,065 |
| 2016-07-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Sale | 1,303 | 30.02 | 39,116 |
| 2016-07-15 | Griffith Christopher M. (VP Corp. Dev. & Strategy) | Option Ex | 1,303 | 1.48 | 1,927 |
| 2016-07-11 | Guggenhime Andrew (COO and CFO) | Sale | 10,000 | 30.04 | 300,400 |
| 2016-07-11 | Guggenhime Andrew (COO and CFO) | Option Ex | 10,000 | 5.51 | 55,100 |
| 2016-07-05 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 2,000 | 30.18 | 60,360 |
| 2016-07-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 29.48 | 73,700 |
| 2016-07-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 9,000 | 29.49 | 265,410 |
| 2016-06-23 | Pena Luis C. (Chief Development Officer) | Sale | 10,000 | 30.01 | 300,100 |
| 2016-06-23 | Pena Luis C. (Chief Development Officer) | Option Ex | 10,000 | 1.74 | 17,400 |
| 2016-06-15 | Pena Luis C. (Chief Development Officer) | Sale | 10,000 | 29.47 | 294,700 |
| 2016-06-15 | Pena Luis C. (Chief Development Officer) | Option Ex | 10,000 | .91 | 9,110 |
| 2016-06-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 31.65 | 79,125 |
| 2016-06-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 31.34 | 344,795 |
| 2016-05-02 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 25.09 | 62,725 |
| 2016-05-02 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 9,000 | 25.11 | 225,990 |
| 2016-04-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 20.84 | 52,100 |
| 2016-04-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 7,000 | 20.69 | 144,830 |
| 2016-02-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 27.57 | 68,937 |
| 2016-02-01 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 9,000 | 27.56 | 248,040 |
| 2016-01-04 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 33.49 | 83,725 |
| 2016-01-04 | Wiggans Thomas G (CEO & Chairman of the Board) | Sale | 11,000 | 33.54 | 368,940 |
| 2015-12-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 30.02 | 75,050 |
| 2015-11-02 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 27.75 | 69,375 |
| 2015-10-01 | Bauer Eugene A (Chief Medical Officer) | Sale | 2,500 | 23.18 | 57,962 |
| 2015-09-14 | Bauer Eugene A (Chief Medical Officer) | Sale | 22,500 | 28.26 | 635,850 |
| 2015-06-29 | Fust Matthew K | Option Ex | 9,051 | 5.51 | 49,871 |
| 2014-11-25 | Fust Matthew K | Buy | 6,000 | 16.77 | 100,602 |
| 2014-10-08 | Canaan Partners Viii Llc | Buy | 49,276 | 16.00 | 788,416 |
| 2014-10-08 | Viswanathan Ravi (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Nea Partners 13, Limited Partnership (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Bay City Capital Fund V Co-investment Fund, L.p. | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Weller Harry R (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Hutton Wende S | Buy | 49,276 | 16.00 | 788,416 |
| 2014-10-08 | Drant Ryan D (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Baskett Forest (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Kolluri Krishna Kittu (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Sandell Scott D (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Kerins Patrick J (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Mott David M (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Barrett M James (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Craves Fred B | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-10-08 | Barris Peter J (10% Owner) | Buy | 69,112 | 16.00 | 1,105,792 |
Insider trading activities including stock purchases, stock sales, and option exercises of DERM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dermira, Inc. (symbol DERM, CIK number 1557883) see the Securities and Exchange Commission (SEC) website.